MDGL icon

Madrigal Pharmaceuticals
MDGL

Overview Fund Activity

301 hedge funds and large institutions have $7.09B invested in Madrigal Pharmaceuticals in 2025 Q2 according to their latest regulatory filings, with 40 funds opening new positions, 104 increasing their positions, 108 reducing their positions, and 51 closing their positions.

Holders
301
Holders Change
-17
Holders Change %
-5.35%
% of All Funds
4.04%
Holding in Top 10
12
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.16%
New
40
Increased
104
Reduced
108
Closed
51
Calls
$271M
Puts
$118M
Net Calls
+$153M
Net Calls Change
-$29.1M

Top Buyers

1
Citadel Advisors
1
Citadel Advisors
Florida
$62.7M
2
Vanguard Group
2
Vanguard Group
Pennsylvania
$568M
3
Adage Capital Partners
3
Adage Capital Partners
Massachusetts
$114M
4
UBS Group
4
UBS Group
Switzerland
$153M
5
Norges Bank
5
Norges Bank
Norway
$53.4M

Top Sellers

1
Holocene Advisors
1
Holocene Advisors
New York
$0
2
Fidelity Investments
2
Fidelity Investments
Massachusetts
$135M
3
WP
3
Woodline Partners
California
$48.3M
4
ACA
4
Avoro Capital Advisors
New York
$567M
5
Morgan Stanley
5
Morgan Stanley
New York
$75M
Name Market Value Shares Shares
Change 		Shares
Change %
American Century Companies
26
American Century Companies
Missouri
$50.8M 167,784 +9,478 +6%
WP
27
Woodline Partners
California
$48.3M 159,623 -157,810 -50%
Charles Schwab
28
Charles Schwab
California
$46.3M 153,085 +1,834 +1%
ACH
29
ArrowMark Colorado Holdings
Colorado
$43.8M 144,808 -35,301 -20%
Northern Trust
30
Northern Trust
Illinois
$43.2M 142,868 -8,018 -5%
RSCM
31
Rock Springs Capital Management
Maryland
$42.5M 140,296 -26,402 -16%
Fiera Capital (Canada)
32
Fiera Capital (Canada)
Quebec, Canada
$39.5M 130,622 -1,557 -1%
AC
33
Armistice Capital
New York
$37.5M 124,000 -11,883 -9%
TCM
34
Tao Capital Management
California
$34.1M 112,785 – –
D.E. Shaw & Co
35
D.E. Shaw & Co
New York
$33.9M 111,981 +12,975 +13%
Point72 Asset Management
36
Point72 Asset Management
Connecticut
$33.6M 110,877 +45,017 +68%
MB
37
MPM BioImpact
Massachusetts
$30.4M 100,415 – –
Connor, Clark & Lunn Investment Management (CC&L)
38
Connor, Clark & Lunn Investment Management (CC&L)
British Columbia, Canada
$30.3M 100,095 -2,265 -2%
TLP
39
Tri Locum Partners
New York
$29.6M 97,765 +59,896 +158%
Bank of New York Mellon
40
Bank of New York Mellon
New York
$26.9M 88,943 +28,154 +46%
Lord, Abbett & Co
41
Lord, Abbett & Co
New Jersey
$25.5M 84,217 -33,807 -29%
AAA
42
Affinity Asset Advisors
New York
$24.2M 80,000 – –
EC
43
EcoR1 Capital
California
$22.7M 75,000 – –
Mirae Asset Global Investments
44
Mirae Asset Global Investments
South Korea
$21.4M 70,559 +218 +0.3%
BNP Paribas Financial Markets
45
BNP Paribas Financial Markets
France
$20.9M 69,037 +65,561 +1,886%
Barclays
46
Barclays
United Kingdom
$19M 62,674 +15,803 +34%
New York State Common Retirement Fund
47
New York State Common Retirement Fund
New York
$18.5M 61,062 +16,291 +36%
B
48
Braidwell
Connecticut
$18.4M 60,781 +12,091 +25%
Franklin Resources
49
Franklin Resources
California
$18.4M 60,715 +41,762 +220%
JPMorgan Chase & Co
50
JPMorgan Chase & Co
New York
$16.9M 55,854 +27,840 +99%
1
2
3 4 5